Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Seres Therapeutics (MCRB)
Technical Analysis Report for NASDAQ stock MCRB Seres Therapeutics. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics then click here. or read Experts views on Seres Therapeutics or Forecast & share price targets of Seres Therapeutics
Seres Therapeutics Opened at 8.71 and Closed at: 8.80, which is -1.82% of previous session's close. It moved within a range of 8.60 and 9.19
The session was a Bullish session with an average volume of 49800, which is 36.55% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
Support for tomorrow is 8.7 and resistance for tomorrow is 9.29
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 8.54, 8.27 resistance for tomorrow's hourly charts is 9.13, 9.45
10 Day SMA for Seres Therapeutics (MCRB) is 8.66 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Seres Therapeutics (MCRB) is 10.2 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Seres Therapeutics (MCRB) is 13.24 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 15.38 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Seres Therapeutics is 14.61 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Seres Therapeutics is at 10.2 and 200 DMA is at 14.61, while 50 DMA and 100 DMA are at 13.24 and 15.38 respectively
Seres Therapeutics (MCRB) moving average of 20 SMA is at 10.2 and 20 EMA is at 10.18
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 8.80 | 10.2 | 10.18 |
| 02 Mon Mar | 8.96 | 10.53 | 10.32 |
| 27 Fri Feb | 8.74 | 10.84 | 10.46 |
| 26 Thu Feb | 8.88 | 11.15 | 10.64 |
| 25 Wed Feb | 8.89 | 11.47 | 10.82 |
| 24 Tue Feb | 8.65 | 11.78 | 11.02 |
Seres Therapeutics (MCRB) moving average of 50 SMA is at 13.24 and 50 EMA is at 12.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 8.80 | 13.24 | 12.56 |
| 02 Mon Mar | 8.96 | 13.37 | 12.71 |
| 27 Fri Feb | 8.74 | 13.5 | 12.86 |
| 26 Thu Feb | 8.88 | 13.65 | 13.03 |
| 25 Wed Feb | 8.89 | 13.79 | 13.2 |
| 24 Tue Feb | 8.65 | 13.95 | 13.38 |
Seres Therapeutics (MCRB) moving average of 100 SMA is at 15.38 and 100 EMA is at 13.89
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 8.80 | 15.38 | 13.89 |
| 02 Mon Mar | 8.96 | 15.48 | 13.99 |
| 27 Fri Feb | 8.74 | 15.6 | 14.09 |
| 26 Thu Feb | 8.88 | 15.72 | 14.2 |
| 25 Wed Feb | 8.89 | 15.84 | 14.31 |
| 24 Tue Feb | 8.65 | 15.96 | 14.42 |
Seres Therapeutics (MCRB) moving average of 200 SMA is at 14.61 and 200 EMA is at 13.01
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 8.80 | 14.61 | 13.01 |
| 02 Mon Mar | 8.96 | 14.6 | 13.05 |
| 27 Fri Feb | 8.74 | 14.59 | 13.09 |
| 26 Thu Feb | 8.88 | 14.59 | 13.13 |
| 25 Wed Feb | 8.89 | 14.58 | 13.17 |
| 24 Tue Feb | 8.65 | 14.57 | 13.21 |
111 Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in 111 Inc, about 36.1% more returns!
Xtl Biopharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 8.34% more returns!
Vanda Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Vanda Pharmaceuticals, about 38.6% more returns!
Tandem Diabetes has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 60.45% more returns!
Summit Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Summit Therapeutics, about 40.23% more returns!
Soleno Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Soleno Therapeutics, about 24.99% more returns!
Surgery Partners has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 34.51% more returns!
Insulet Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Insulet Corporation, about 31.7% more returns!
Lemaitre Vascular has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 59.71% more returns!
Kezar Life has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Kezar Life, about 52.6% more returns!
Abeona Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 32.68% more returns!
Acadia Healthcare has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 105.11% more returns!
Aldeyra Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 33.33% more returns!
Amgen Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 38.39% more returns!
Atossa Genetics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Atossa Genetics, about 24.66% more returns!
Exelixis Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 30.96% more returns!
Gilead Sciences has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 36.53% more returns!
Seres Therapeutics Technical analysis of indicators
Price action analysis of Seres Therapeutics (MCRB) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Seres Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Seres Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Seres Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Seres Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Seres Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.58 and Seres Therapeutics MCRB stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Seres Therapeutics MCRB stock. Volume based technical analysis of Seres Therapeutics MCRB stock is negative.
Seres Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock MCRB Seres Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MCRB Experts View which covers a lot of information including buying and selling signals
MCRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Seres Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


